https://www.pharmatlas.org/ 2026-04-16T17:08:47+00:00 https://www.pharmatlas.org/ https://www.pharmatlas.org/lib/exe/fetch.php?media=logo.png text/html 2026-02-13T00:47:00+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:aspart&rev=1770943620&do=diff Insulin Aspart Insulin aspart is a rapid-acting insulin analog used for prandial (mealtime) glucose control. It has a fast onset and short duration, closely mimicking physiologic mealtime insulin secretion. → Insulin Therapy ---------- Mechanism of Action Insulin aspart binds to the insulin receptor (tyrosine kinase receptor). text/html 2026-02-13T00:48:27+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:degludec&rev=1770943707&do=diff Insulin Degludec Insulin degludec is an ultra-long-acting basal insulin analog used for background glucose control. It provides a very flat, prolonged insulin profile lasting over 24 hours. → Insulin Therapy ---------- Mechanism of Action Degludec binds to the insulin receptor (tyrosine kinase receptor). text/html 2026-02-13T00:48:57+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:detemir&rev=1770943737&do=diff Insulin Detemir Insulin detemir is a long-acting basal insulin analog used for background glucose control. It provides steady insulin levels but may require once- or twice-daily dosing depending on patient needs. → Insulin Therapy ---------- Mechanism of Action text/html 2026-02-13T00:49:35+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:glargine&rev=1770943775&do=diff Insulin Glargine Insulin glargine is a long-acting basal insulin analog used for background glucose control. It provides a relatively flat, 24-hour insulin profile with minimal peak. → Insulin Therapy ---------- Mechanism of Action Glargine binds to the insulin receptor (tyrosine kinase receptor). text/html 2026-02-13T00:47:55+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:glulisine&rev=1770943675&do=diff Insulin Glulisine Insulin glulisine is a rapid-acting insulin analog used for prandial (mealtime) glucose control. It has a rapid onset and short duration similar to other rapid-acting analogs. → Insulin Therapy ---------- Mechanism of Action Insulin glulisine binds to the insulin receptor (a tyrosine kinase receptor). text/html 2026-02-13T00:46:31+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:lispro&rev=1770943591&do=diff Insulin Lispro Insulin lispro is a rapid-acting insulin analog used for prandial (mealtime) glucose control. It has a faster onset and shorter duration than regular insulin. → Insulin Therapy ---------- Mechanism of Action Insulin lispro binds to the insulin receptor (tyrosine kinase receptor). text/html 2026-02-13T00:50:03+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:nph&rev=1770943803&do=diff NPH Insulin NPH (Neutral Protamine Hagedorn) insulin is an intermediate-acting insulin used for basal glucose control. It has a pronounced peak and shorter duration compared to long-acting insulin analogs. → Insulin Therapy ---------- Mechanism of Action NPH insulin binds to the insulin receptor (tyrosine kinase receptor). text/html 2026-02-13T00:47:27+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:regular&rev=1770943647&do=diff Regular Insulin Regular insulin is short-acting human insulin used for prandial control and intravenous insulin therapy. It has a slower onset and longer duration than rapid-acting insulin analogs. → Insulin Therapy ---------- Mechanism of Action Regular insulin binds to the insulin receptor (tyrosine kinase receptor). text/html 2026-02-13T00:52:32+00:00 Anonymous (anonymous@undisclosed.example.com) https://www.pharmatlas.org/doku.php?id=endocrine:insulin:start&rev=1770943952&do=diff Insulin Therapy Insulin is the most effective glucose-lowering therapy available. It replaces or supplements endogenous insulin when pancreatic beta-cell function is inadequate or absent. Used in: * Type 1 Diabetes (required) * Advanced Type 2 Diabetes